What is DHB?
DHB (dihydroboldenone, also 1-testosterone) is a potent anabolic structurally related to boldenone but stronger and without aromatization. It delivers dry, hard gains with a good strength component. The injectable form is notorious for severe injection site pain - the oral form avoids that.
This information is for research and educational purposes only. No medical advice.
Comparison
1-testosterone and relatives
Related steroids at the same receptor, as described in the TPD lexicon. Tap a card to open its entry.
How it works
DHB activates the androgen receptor strongly, does not aromatize and causes no estrogen side effects. Gains are dry and high quality, the anabolic-to-androgenic ratio is considered favorable.
Where it acts
Where 1-testosterone acted in experiments
Tap a point or a card. Red = androgen receptor, grey = observed. Animal data and one trial with a precursor.
- Levator ani muscle (rat)
Grew as much as with testosterone propionate1
AR - Prostate and seminal vesicles (rat)
Grew as much as with testosterone propionate1
AR - Liver
Liver weight rose in rats, AST +113.8% with the precursor1
Observed in trials - Blood lipids
HDL -38.7%, LDL +32.8% with the precursor2
Observed in trials - Kidney
Creatinine +19.6%, filtration rate -18% with the precursor2
Observed in trials - Fat tissue
Fat mass -24.6% with precursor and training (placebo -9.5%)2
Observed in trials
Known targets1
Compound PubChem CID 236666: one described target, Agonist, binds very selectively (cell assay).
- Gene
- AR
- UniProt
- P10275
- ChEMBL
- CHEMBL1871
- Action
- Agonist, binds very selectively (cell assay)
Use and dosing
Dosing
Dosing, titration and syringe
Loading the dosing information …
- Getting started and stepping up, drawn as a staircase
- Units on the U-100 syringe for every step
- How long one vial lasts
What the research shows
Compound-specific human studies are scarce. The AAS pharmacology (Kicman 2008, Hartgens & Kuipers 2004) classes the properties of non-aromatizing anabolics.
Study results
What the trials measured
Interactive: switch tabs, tap points, show or hide arms. Arms are named relative to each other, no dosing advice.
Strength training with a precursor of 1-testosterone2
Change over 4 weeks in percent, 17 trained men, oral precursor against placebo
The trial tested 1-androsterone, an oral precursor, not DHB. In the urine of a volunteer it showed up as 1-testosterone among other metabolites. Small 4-week trial, all values as stated in the abstract.
Blood values on the precursor2
Change over 4 weeks in percent, same trial
None of these values changed significantly on placebo. The authors conclude that the harm to the cardiovascular system and the liver outweighs the benefit.
Research status
Where the research stands
DHB itself has never been tested in a registered human trial, neither as a tablet nor as an injection. As of 26 Oct 2026. 6
- Preclinical Cell assays and rats
- Phase 1 no registered trial
- Phase 2 no registered trial
- Phase 3 no registered trial
- Approval not yet
So far there is no registered trial in humans. 6
Side effects
Storage
Store dry and cool, protected from light. Out of reach of children.